Older HPV vaccine cuts cervical cancer rate up to 87%, study finds
Young women who were vaccinated against human papillomavirus in their teens with an older GlaxoSmithKline product called Cervarix had up to an 87% lower risk of developing cervical cancer linked... #glaxosmithkline #thelancet
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Genital Warts | Health | Human Papillomavirus (HPV) | Study | Vaccines | Women